B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Naringenin

A group of FLAVONOLS based on kaempferol. They are derived from naringenin and can be hydroxylated to QUERCETIN or reduced to leucopelargonidin.

300 PubMed studies analyzed · 2 RCTs · Evidence Score: 42.5

Research Domains

Naringenin has been studied across 23 research domains including 🔬 Inflammation, 🔬 Oncology, 🧘 Stress & Anxiety, 🫁 Liver & Detox, 🔥 Metabolic. The primary research focus is 🔬 Inflammation with 26% of studies addressing this area.

Loading evidence profile...

This evidence profile for Naringenin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.